Synyi AI, a
Tencent-backed Chinese startup, launched a trial clinic in Saudi Arabia in April to test AI-led diagnoses and prescriptions under human doctor oversight. Backed by Almoosa Health Group, the pilot covers 30 respiratory conditions and is generating regulatory data. The company aims to enter commercial use within 18 months.